Komen Scholars

The Komen Scholars (formerly known as the Scientific Advisory Council or SAC) are an advisory group of 70 distinguished scholars and leaders in breast cancer research and advocacy who have made significant contributions to advancing the field or who demonstrate significant promise of leading the field with important advances in the future and are committed to furthering Komen's mission.   

This new group of scientific advisors was established in 2010 and is led by the Scientific Advisory Board (SAB), which serves as the executive committee. Komen Scholars advise and provide expertise to Susan G. Komen for the Cure in a variety of capacities, with primary responsibility for leading and participating as reviewers in Komen's scientific peer review process.  Komen Scholars also contribute in other ways to Komen's mission-related programs, for example by presenting educational seminars and webinars; contributing to the development of educational materials; serving as representatives to the media/public; participating in the development of policy positions and other initiatives; serving as scientific advisors and participating in Komen-led think tank meetings and other Komen-sponsored programs; and collaborating with local Affiliates. 

 The Komen Scholars  are an international group—representing 35 institutions in Belgium, Canada, England, Israel, Italy, Switzerland, and the US—and span a wide range of expertise, including clinical research, laboratory research, pathology, prevention, radiation oncology, surgery, and other research disciplines and specialties.  Within the group there are 42 full members (established senior scholars and leaders in the field of breast cancer), 12 associate members (independent investigators at earlier stages of their careers), and 9 special members (individuals meeting criteria for full or associate membership who are PIs or Co-PIs on Komen Promise Grants or other large grants).  As researchers themselves, these 63 Scholars must be involved in innovative projects that seek to discover and deliver the cures for breast cancer.  In addition, 7 of the Scholars are Advocates in Science who ensure that the unique perspectives of those affected by breast cancer are fully integrated into decisions at every step of the research process. 

Komen Scholars: 2012 - 2013
	Benjamin Anderson, M.D. Fred Hutchinson Cancer Research Center Seattle, WA		Alan Ashworth, F.R.S.  Breakthrough Breast Cancer Research Centre, Institute of Cancer Research London, England
	Sunil Badve, M.D., F.R.C.Path  Indiana University Simon Cancer Center Indianapolis, IN		Jose Baselga. M.D.  Massachusetts General Hospital Boston, MA
	Kimberly Blackwell, M.D.  Duke University School of Medicine Durham, NC		Gerard Blobe, M.D., Ph.D.  Duke University School of Medicine Durham, NC
	Melissa Bondy, Ph.D. Baylor College of Medicine Houston, TX		Joan Brugge, Ph.D. Harvard Medical School Boston, MA
	Lisa Carey, M.D. UNC Lineberger Comprehensive Cancer Center Chapel Hill, NC		Claire Dees, M.D., Ms.C. UNC Lineberger Comprehensive Cancer Center Chapel Hill, NC
	Angelo Di Leo, M.D., Ph.D. Hospital of Prato Istituto Toscano Tumori Prato, Italy		Nora Disis, M.D. University of Washington Seattle, WA
	Susan Domchek, M.D. Abramson Cancer Center University of Pennsylvania Philadelphia, PA		Mary Elliott Komen Advocate in Science Bastrop, TX
	Matthew Ellis, M.D., Ph.D. Washington University School of Medicine St. Louis, MO		Carol Fabian, M.D. University of Kansas Medical Center Westwood, KS
	Sandra Finestone, PsyD. Komen Advocate in Science Costa Mesa, CA		Silvia Formenti, M.D. New York University School of Medicine and Langone Medical Center New York, NY
	William Foulkes, M.B., Ph.D. McGill University Montreal, Canada		Patricia Ganz, M.D. University of California, Los Angeles Los Angeles, CA
	Judy Garber, M.D., MPH Dana-Farber Cancer Institute Boston, MA		Ana Gonzalez-Angulo, M.D., M.Sc., F.A.C.P. University of Texas M.D. Anderson Cancer Center Houston, TX
	Julie Gralow, M.D. University of Washington School of Medicine and Seattle Cancer Care Alliance Seattle, WA		Joe Gray, Ph.D. Knight Cancer Institute Oregon Health & Science University Portland, OR
	Theresa Guise, M.D. Indiana University School of Medicine Indianapolis, IN		Susan Hankinson, Sc.D. Brigham and Women's Hospital and Harvard Medical School Boston, MA
	Daniel Hayes, M.D. University of Michigan Health System Ann Arbor, MI		Mien-Chie Hung, Ph.D. University of Texas M.D. Anderson Cancer Center Houston, TX
	Nola Hylton, Ph.D. University of California, San Francisco San Francisco, CA		Nancy Hynes, Ph.D. Friedrich Miescher Institute for Biomedical Research Basel, Switzerland
	Peggy Johnson Komen Advocate in Science St. Louis, MO		Virgil (Craig) Jordan, OBE, Ph.D., D.Sc. Lombardi Comprehensive Cancer Center Georgetown University Medical Center Washington, DC
	Bella Kaufman, M.D. Chaim Sheba Medical Centre Ramat Gan, Israel		Mary-Claire King, Ph.D. University of Washington School of Medicine Seattle, WA
	Ian Krop, M.D., Ph.D. Dana-Farber Cancer Institute Boston, MA		Beverly Laird,  Ph.D. Komen Advocate in Science Birmingham, AL
	Adrian Lee,  Ph.D. University of Pittsburgh Cancer Institute Pittsburgh, PA		David Livingston, M.D. Dana-Farber Cancer Institute and Harvard Medical School Boston, MA
	H. Kim Lyerly, M.D. Duke University School of Medicine Durham, NC		Eleftherios Mamounas, M.D., M.P.H. Aultman Cancer Center and Northeastern Ohio Universities College of Medicine Canton, OH
	David Mankoff, M.D., Ph.D. University of Pennsylvania Perelman School of Medicine Philadelphia, PA		Anne McTiernan, M.D., Ph.D. Fred Hutchinson Cancer Research Center and University of Washington School of Medicine Seattle, WA
	Funda Meric-Bernstam, M.D. University of Texas M.D. Anderson Cancer Center Houston, TX		Kathy Miller, M.D. Indiana University Simon Cancer Center Indianapolis, IN
	Gordon Mills, M.D., Ph.D. University of Texas M.D. Anderson Cancer Center Houston, TX		Harikrishna Nakshatri, B.V.Sc. (DVM), Ph.D. Indiana University School of Medicine Indianapolis, IN
	Olufunmilayo Olopade, M.D., F.A.C.P. University of Chicago Medical Center Chicago, IL		Bert O'Malley, M.D. Baylor College of Medicine Houston, TX
	Ramon Parsons, M.D., Ph.D. Columbia University Medical Center New York, NY		Ann Partridge, M.D., M.P.H. Dana-Farber Cancer Institute Boston, MA
	Rena Pasick, Dr.PH UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, CA		Lori Pierce, M.D. University of Michigan Health System Ann Arbor, MI
	Jennifer Pietenpol, Ph.D. Vanderbilt-Ingram Cancer Center Nashville, TN		Jeffrey Rosen, Ph.D. Baylor College of Medicine Houston, TX
	Bryan P. Schneider, M.D. Indiana University Simon Cancer Center  Indianapolis, IN		Andrew Seidman, M.D. Memorial Sloan-Kettering Cancer Center New York, NY
	Christos Sotiriou, M.D. Ph.D. Jules Bordet Institute Brussels, Belgium		Patricia Spears Komen Advocate in Science Raleigh, NC
	Neil Spector, M.D. Duke University School of Medicine Durham, NC		Vered Stearns, M.D. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine Baltimore, MD
	Sara Sukumar, Ph.D. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine Baltimore, MD		William Symmans, M.D. University of Texas M.D. Anderson Cancer Center Houston, TX
	Chris Tannous, Ph.D. Komen Advocate in Science Fountain Valley, CA		Thea Tlsty, Ph.D. University of California, San Francisco San Francisco, CA
	Geoffrey Wahl, Ph.D. The Salk Institute for Biological Studies La Jolla, CA		Danny Welch, Ph.D. The Kansas University Medical Center Kansas City, KS
	Julia White, M.D. Stephanie Spielman Comprehensive Breast Center, The Ohio State University Medical School Columbus, OH		Antonio Wolff, M.D. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine Baltimore, MD
	Kimberly Wright Komen Advocate in Science Reisterstown, MD		Douglas Yee, M.D. Masonic Cancer Center University of Minnesota Minneapolis, MN